ARHGEF4 predicts poor prognosis and promotes cell invasion by influencing ERK1/2 and GSK-3α/β signaling in pancreatic cancerKeisuke Taniuchi(Kōchi University), Toshiji Saibara(Kōchi University)International Journal of OncologyAugust 31, 201810.3892/ijo.2018.4549Cited by 11SaveCiteExport RISWatch citationsRelated PapersInhibitory effects of the combination of rapamycin with gemcitabine plus paclitaxel on the growth of pancreatic cancer tumors|Human Cell|2025|3